• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Sabra Issues Business Update and Increases Full-Year 2026 Guidance

    7/21/26 9:05:00 AM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate
    Get the next $SBRA alert in real time by email

    Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced a business update detailed below.

    Portfolio Update

    Sabra has entered into letters of intent to re-tenant all of its 26 properties leased to Avamere ("Avamere"). Under the proposed transition, 22 properties would be transitioned to subsidiaries of Cascadia Healthcare ("Cascadia"), a leading diversified healthcare operator concentrated in the Pacific Northwest with approximately 80 facilities pro forma for this announcement. Founded in 2015 by CEO, Owen Hammond, who was previously the President of Signum Healthcare, a subsidiary of the Ensign Group ("Ensign") covering the entire state of California, Cascadia has established a strong reputation of operational excellence focused on empowering local leaders to drive superior clinical outcomes. The remaining four properties would be transitioned to subsidiaries of an existing Sabra tenant, expanding a long-standing and valued partnership with a national leader in the skilled nursing and post-acute industry.

    Upon closing, the combined annualized cash rent of this portfolio is expected to be $53 million, a nearly 30% increase compared to the $41 million of cash rent received from Avamere during the trailing-twelve-month period ending March 31, 2026. The transition is expected to be completed during the second half of 2026.

    In addition, Sabra has closed on, or entered into agreements for, several smaller portfolio initiatives (e.g., re-tenanting properties, rent resets, lease amendments) that will collectively increase cash NOI by over $9 million per year on a run-rate basis compared to the twelve-month period ending March 31, 2026. Most of these transactions have closed as of the date of this announcement, and the remainder are expected to close in the second half of 2026.

    RCA Mortgage

    Sabra and Recovery Centers of America ("RCA") have agreed to a reduced cash repayment of $200 million in full satisfaction of the $300 million mortgage, which had been scheduled to mature on November 1, 2026. The repayment transaction closed on June 30, 2026, and proceeds were used to reduce the balance on Sabra’s revolving line of credit. Pro forma for this announcement, as of March 31, 2026, Sabra’s Net Debt to EBITDA declined from 5.0x to 4.8x, while behavioral health concentration has declined from 13% of Annualized Cash NOI, to 9%, respectively.

    Full-Year 2026 Guidance Increased

    Incorporating the events described above, as well as taking into consideration year-to-date operational performance and transaction activity, full-year 2026 guidance ranges have been updated as follows (attributable to Sabra Health Care REIT, Inc., per diluted common share):

    • Net Income: $0.37 - $0.39
    • FFO: $1.12 - $1.14
    • Normalized FFO: $1.53 - $1.55
    • AFFO: $1.58 - $1.60
    • Normalized AFFO: $1.59 - $1.61

    Earnings guidance above assumes:

    • low-single-digit Cash NOI growth for the triple-net portfolio at the midpoint, ignoring the impact of acquisitions, dispositions and completed or planned tenant transitions;
    • average full-year Cash NOI growth for the same-store Senior Housing - Managed portfolio in the low-to-mid teens;
    • general and administrative expenses at the midpoint of $61 million, which includes $13 million of stock-based compensation expense;
    • cash interest expense of $104 million at the midpoint;
    • weighted average share count of 258 million and 259 million for Normalized FFO and Normalized AFFO, respectively;
    • only investments, dispositions and capital markets activity completed as of July 21, 2026.

    The foregoing guidance ranges reflect management’s view of current and future market conditions. There can be no assurance that the Company’s actual results will not differ materially from the estimates set forth above. Except as otherwise required by law, the Company assumes no, and hereby disclaims any, obligation to update any of the foregoing guidance ranges as a result of new information or new or future developments.

    Commenting on the business update, Rick Matros, CEO and Chair, said, "We are pleased to announce this positive business update which highlights the execution of our strategy to increase shareholder value through enhanced portfolio quality, improved earnings growth and a focus on investing in our core senior housing and skilled nursing segments. These efforts have allowed us to increase our full-year 2026 guidance; at the midpoint, Normalized FFO and Normalized AFFO per share are now expected to increase by 7% and 8%, respectively, over 2025.

    "The Avamere transition has been well-planned and is benefiting from a high level of cooperation across the various parties involved, following outreach to Sabra earlier this year by founder, Rick Miller, who indicated a desire to exit the skilled nursing business. We are excited for the next chapter of this important portfolio as Cascadia and our existing tenant are committed to continuing Avamere’s legacy of providing high-quality clinical outcomes. Importantly, Cascadia has previous experience successfully taking over operations of non-Sabra Avamere facilities.

    "With respect to the RCA mortgage, exiting that investment reduces our behavioral health concentration as well as our leverage, thereby strengthening our portfolio and balance sheet. Redirecting our efforts towards investing in our core segments, rather than extending the loan, made the most sense from a value creation perspective. Importantly, including interest income earned since 2021, we have more than recouped our initial investment.

    "Strengthening the portfolio through these transactions, as well as through incremental benefits from ongoing, proactive portfolio management, will further allow the Sabra team to stay focused on increasing our managed senior housing concentration, while still opportunistically executing on skilled nursing investments."

    About Sabra

    Sabra Health Care REIT, Inc., a Maryland corporation, operates as a self-administered, self-managed real estate investment trust (a "REIT") that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada.

    FORWARD-LOOKING STATEMENTS SAFE HARBOR

    This release contains "forward-looking" statements as defined in the Private Securities Litigation Reform Act of 1995. Any statements that do not relate to historical or current facts or matters are forward-looking statements. These statements may be identified, without limitation, by the use of "expects," "believes," "intends," "should" or comparable terms or the negative thereof. Examples of forward-looking statements include all statements regarding our other expectations regarding our future financial position (including our earnings guidance for 2026, as well as the assumptions set forth therein); our expectations regarding the proposed transition of the Avamere facilities; our expectations regarding our other portfolio initiatives; our expectations regarding our results of operations, cash flows, liquidity, business strategy, growth opportunities, potential investments and dispositions; our expectations regarding our investment activity; and our plans and objectives for future operations.

    Our actual results may differ materially from those projected or contemplated by our forward-looking statements as a result of various factors, including, among others, the following: our ability to complete the proposed transition of the Avamere facilities on the expected terms or at all; our ability to complete our other portfolio initiatives on the expected terms or at all; increases in market interest rates and inflation; pandemics or epidemics, and the related impact on our tenants, borrowers and senior housing - managed communities; operational risks with respect to our senior housing - managed communities; increased labor costs and labor shortages; competitive conditions in our industry; the loss of key management personnel; uninsured or underinsured losses affecting our properties; potential impairment charges and adjustments related to the accounting of our assets; risks associated with our investment in our unconsolidated joint ventures; catastrophic weather and other natural or man-made disasters, the effects of climate change on our properties and a failure to implement sustainable and energy-efficient measures; increased operating costs and competition for our tenants, borrowers and senior housing - managed communities; increased healthcare regulation and enforcement; our tenants’ dependency on reimbursement from governmental and other third-party payor programs; the effect of our tenants, operators or borrowers declaring bankruptcy or becoming insolvent; our ability to find replacement tenants and the impact of unforeseen costs in acquiring new properties; the impact of litigation and rising insurance costs on the business of our tenants; the impact of required regulatory approvals of transfers of healthcare properties; environmental compliance costs and liabilities associated with real estate properties we own; our tenants’, borrowers’ or operators’ failure to adhere to applicable privacy and data security laws; a material breach of our or our tenants’, borrowers’ or operators’ information technology; our concentration in the healthcare property sector, particularly in skilled nursing/transitional care facilities and senior housing communities, which makes our profitability more vulnerable to a downturn in a specific sector than if we were investing in multiple industries; the significant amount of and our ability to service our indebtedness; covenants in our debt agreements that may restrict our ability to pay dividends, make investments, incur additional indebtedness and refinance indebtedness on favorable terms; adverse changes in our credit ratings; our ability to make dividend distributions at expected levels; our ability to raise capital through equity and debt financings; changes and uncertainty in macroeconomic conditions and disruptions in the financial markets; risks associated with our ownership of property outside the U.S., including currency fluctuations; the relatively illiquid nature of real estate investments; our ability to maintain our status as a real estate investment trust ("REIT") under the federal tax laws; compliance with REIT requirements and certain tax and tax regulatory matters related to our status as a REIT; changes in tax laws and regulations affecting REITs; the ownership limits and takeover defenses in our governing documents and under Maryland law, which may restrict change of control or business combination opportunities; and the exclusive forum provisions in our bylaws.

    Additional information concerning risks and uncertainties that could affect our business can be found in our filings with the Securities and Exchange Commission (the "SEC"), including in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2025. We do not intend, and we undertake no obligation, to update any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, unless required by law to do so.

     

    SABRA HEALTH CARE REIT, INC.

    RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES

    2026 Outlook

     

    The table below sets forth our 2026 guidance (per diluted common share):

     

     

    Low

     

    High

    Net income attributable to Sabra Health Care REIT, Inc.

    $

    0.37

     

     

    $

    0.39

     

    Add:

     

     

     

    Depreciation and amortization of real estate assets

     

    0.88

     

     

     

    0.88

     

    Depreciation and amortization of real estate assets related to unconsolidated joint ventures

     

    0.02

     

     

     

    0.02

     

    Net gain on sales of real estate

     

    (0.15

    )

     

     

    (0.15

    )

    FFO attributable to Sabra Health Care REIT, Inc.

    $

    1.12

     

     

    $

    1.14

     

    Normalizing items

     

    0.41

     

     

     

    0.41

     

    Normalized FFO attributable to Sabra Health Care REIT, Inc.

    $

    1.53

     

     

    $

    1.55

     

    FFO attributable to Sabra Health Care REIT, Inc.

    $

    1.12

     

     

    $

    1.14

     

    Stock-based compensation expense

     

    0.05

     

     

     

    0.05

     

    Non-cash rental and related revenues

     

    (0.02

    )

     

     

    (0.02

    )

    Non-cash interest expense

     

    0.04

     

     

     

    0.04

     

    Other adjustments

     

    0.39

     

     

     

    0.39

     

    AFFO attributable to Sabra Health Care REIT, Inc.

    $

    1.58

     

     

    $

    1.60

     

    Normalizing items

     

    0.01

     

     

     

    0.01

     

    Normalized AFFO attributable to Sabra Health Care REIT, Inc.

    $

    1.59

     

     

    $

    1.61

     

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260721768789/en/

    Investor & Media Inquiries: 1-888-393-8248 or investorinquiries@sabrahealth.com

    Get the next $SBRA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SBRA

    DatePrice TargetRatingAnalyst
    7/8/2026Buy → Hold
    Truist
    7/7/2026$21.00Overweight
    Barclays
    6/23/2026$19.00Buy → Neutral
    Citigroup
    6/17/2026Underperform
    Raymond James
    11/18/2025$20.00Neutral
    UBS
    10/1/2025$20.00Neutral
    Cantor Fitzgerald
    1/17/2025Buy → Hold
    Truist
    1/7/2025$20.00Mkt Perform → Mkt Outperform
    JMP Securities
    More analyst ratings

    $SBRA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Sabra Health Care REIT downgraded by Truist

    Truist downgraded Sabra Health Care REIT from Buy to Hold

    7/8/26 8:26:47 AM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    Barclays initiated coverage on Sabra Health Care REIT with a new price target

    Barclays initiated coverage of Sabra Health Care REIT with a rating of Overweight and set a new price target of $21.00

    7/7/26 8:48:47 AM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    Sabra Health Care REIT downgraded by Citigroup with a new price target

    Citigroup downgraded Sabra Health Care REIT from Buy to Neutral and set a new price target of $19.00

    6/23/26 8:21:39 AM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    $SBRA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Malehorn Jeffrey A. was granted 8,310 shares, increasing direct ownership by 8% to 116,346 units (SEC Form 4)

    4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)

    6/18/26 6:34:49 PM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    Director Kono Ann was granted 8,310 shares, increasing direct ownership by 14% to 68,186 units (SEC Form 4)

    4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)

    6/18/26 6:34:19 PM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    Director Katzmann Lynne S was granted 8,310 shares, increasing direct ownership by 11% to 86,121 units (SEC Form 4)

    4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)

    6/18/26 6:34:14 PM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    $SBRA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Cusack Catherine bought $40,315 worth of shares (2,500 units at $16.13), increasing direct ownership by 4% to 60,583 units (SEC Form 4)

    4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)

    2/25/25 5:04:04 PM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    Cusack Catherine bought $101,010 worth of shares (7,000 units at $14.43), increasing direct ownership by 18% to 46,385 units (SEC Form 4)

    4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)

    5/23/24 7:00:45 PM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    $SBRA
    SEC Filings

    View All

    Sabra Health Care REIT Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Sabra Health Care REIT, Inc. (0001492298) (Filer)

    7/21/26 9:05:09 AM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    Sabra Health Care REIT Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Sabra Health Care REIT, Inc. (0001492298) (Filer)

    6/17/26 4:40:19 PM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    Sabra Health Care REIT Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Sabra Health Care REIT, Inc. (0001492298) (Filer)

    5/28/26 4:05:22 PM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    $SBRA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Sabra Issues Business Update and Increases Full-Year 2026 Guidance

    Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced a business update detailed below. Portfolio Update Sabra has entered into letters of intent to re-tenant all of its 26 properties leased to Avamere ("Avamere"). Under the proposed transition, 22 properties would be transitioned to subsidiaries of Cascadia Healthcare ("Cascadia"), a leading diversified healthcare operator concentrated in the Pacific Northwest with approximately 80 facilities pro forma for this announcement. Founded in 2015 by CEO, Owen Hammond, who was previously the President of Signum Healthcare, a subsidiary of the Ensign Group ("Ensign") covering the entire state of California

    7/21/26 9:05:00 AM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    Sabra Health Care REIT, Inc. Announces Second Quarter 2026 Earnings Release Date and Conference Call

    Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2026 second quarter earnings release on August 3, 2026, after the close of trading.A conference call with a simultaneous webcast to discuss the 2026 second quarter results will be held on Tuesday, August 4th at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596.The webcast URL is https://events.q4inc.com/attendee/256627291. A digital replay of the call will be available on our website at www.sabrahealth.com.About SabraSabra Health Care REIT, Inc., a Maryland corporation, ope

    7/20/26 4:05:00 PM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    Sabra Health Care REIT, Inc., Issues Business Update and will Participate in Nareit's REITweek 2026 Investor Conference

    In conjunction with upcoming investor meetings, Sabra Health Care REIT, Inc. (NASDAQ:SBRA) has issued a business update, which is available on the company's website. In addition, Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the company's Chief Financial Officer, Darrin Smith, the company's Chief Investment Officer, and Lukas Hartwich, the company's Executive Vice President of Finance, will participate in Nareit's REITweek 2026 Investor Conference June 1 – 4, 2026 at the New York Hilton Midtown in New York, New York. About Sabra Sabra Health Care REIT, Inc., a Maryland corporation, operates as a self-administered, self-managed real estate investment trus

    5/28/26 4:05:00 PM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    $SBRA
    Financials

    Live finance-specific insights

    View All

    Sabra Issues Business Update and Increases Full-Year 2026 Guidance

    Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced a business update detailed below. Portfolio Update Sabra has entered into letters of intent to re-tenant all of its 26 properties leased to Avamere ("Avamere"). Under the proposed transition, 22 properties would be transitioned to subsidiaries of Cascadia Healthcare ("Cascadia"), a leading diversified healthcare operator concentrated in the Pacific Northwest with approximately 80 facilities pro forma for this announcement. Founded in 2015 by CEO, Owen Hammond, who was previously the President of Signum Healthcare, a subsidiary of the Ensign Group ("Ensign") covering the entire state of California

    7/21/26 9:05:00 AM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    Sabra Health Care REIT, Inc. Announces Second Quarter 2026 Earnings Release Date and Conference Call

    Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2026 second quarter earnings release on August 3, 2026, after the close of trading.A conference call with a simultaneous webcast to discuss the 2026 second quarter results will be held on Tuesday, August 4th at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596.The webcast URL is https://events.q4inc.com/attendee/256627291. A digital replay of the call will be available on our website at www.sabrahealth.com.About SabraSabra Health Care REIT, Inc., a Maryland corporation, ope

    7/20/26 4:05:00 PM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    Sabra Reports First Quarter 2026 Results; Reiterates 2026 Guidance

    Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the first quarter of 2026. FIRST QUARTER 2026 RESULTS AND RECENT EVENTS Results per diluted common share for the first quarter of 2026 were as follows: Net Income: $0.16 FFO: $0.37 Normalized FFO: $0.38 AFFO: $0.39 Normalized AFFO: $0.39 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.46x Senior Housing - Leased: 1.58x Behavioral Health, Specialty Hospitals and Other: 4.00x On a year-over-year basis, same property managed senior housing Cash NOI increased 14.4% for the first quarter of 2026. In the first quarter

    4/29/26 4:05:00 PM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    $SBRA
    Leadership Updates

    Live Leadership Updates

    View All

    Sabra Health Care REIT, Inc. Appoints Darrin Smith as Chief Investment Officer and Congratulates Talya Nevo-Hacohen on her Retirement

    Sabra Health Care REIT, Inc. ("Sabra") (NASDAQ:SBRA) today announced that Darrin Smith has been appointed Sabra's Chief Investment Officer, Secretary and Executive Vice President, effective January 1, 2026. Mr. Smith succeeds Talya Nevo-Hacohen, Sabra's former Chief Investment Officer, Treasurer and Executive Vice President in connection with her retirement on December 31, 2025. From March 2020 until his appointment as Chief Investment Officer, Mr. Smith served as Sabra's Executive Vice President, Investments. Mr. Smith previously served as Senior Vice President—Senior Housing Investments at HCP, Inc. (now Healthpeak Properties, Inc.), a healthcare REIT, from January 2010 through December

    1/5/26 9:15:00 AM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    Sabra Health Care REIT Appoints Jessica Flores as Chief Accounting Officer

    Sabra Health Care REIT, Inc. ("Sabra") (NASDAQ:SBRA) today announced that Jessica Flores has been appointed Executive Vice President and Chief Accounting Officer and, in such capacity, has been designated by the Company's Board of Directors as the Company's principal accounting officer. Ms. Flores currently serves as Sabra's Senior Vice President – Finance and Controller, a position she has held since January 2022. Ms. Flores joined Sabra in March 2011 and held various leadership positions overseeing Sabra's accounting during that time. Ms. Flores has over 15 years of experience in accounting, finance and real estate investments, having previously worked for KBS Realty Advisors and Deloit

    1/4/24 9:15:00 AM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    Sabra Health Care REIT Appoints Katie Cusack to its Board of Directors

    IRVINE, Calif.--(BUSINESS WIRE)--Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) today announced the appointment of Katie Cusack to its Board of Directors. Ms. Cusack currently serves as Chief Operating Officer of Cornell Capital LLC, a $4 billion private investment firm with offices in New York and Hong Kong. From 2007 to 2020, Ms. Cusack served in various capacities at Credit Suisse, including Chief Operating Officer for the Investment Banking Division in both Asia Pacific and Europe, Middle East and Africa, and as the Head of Ultra-High Net Worth Coverage. Prior to joining Credit Suisse, Ms. Cusack served as a Managing Director at MTS Health Partners LP, where she provided

    1/12/21 9:05:00 AM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    $SBRA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Sabra Health Care REIT Inc.

    SC 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)

    10/18/24 11:35:05 AM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    SEC Form SC 13G/A filed by Sabra Health Care REIT Inc. (Amendment)

    SC 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)

    2/13/24 5:13:53 PM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    SEC Form SC 13G/A filed by Sabra Health Care REIT Inc. (Amendment)

    SC 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)

    2/13/24 2:19:42 PM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate